- Home
- ZCMD vs QLGN Comparison
ZCMD vs QLGN Comparison
Compare ZCMD & QLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- QLGN
- Stock Information
- Founded
- ZCMD 2012
- QLGN 1996
- Country
- ZCMD China
- QLGN United States
- Employees
- ZCMD N/A
- QLGN 4
- Industry
- ZCMD Other Consumer Services
- QLGN Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- QLGN Health Care
- Exchange
- ZCMD Nasdaq
- QLGN Nasdaq
- Market Cap
- ZCMD 3.4M
- QLGN 2.7M
- IPO Year
- ZCMD 2020
- QLGN N/A
- Fundamental
- Price
- ZCMD $1.20
- QLGN $3.60
- Analyst Decision
- ZCMD
- QLGN
- Analyst Count
- ZCMD 0
- QLGN 0
- Target Price
- ZCMD N/A
- QLGN N/A
- AVG Volume (30 Days)
- ZCMD 15.1K
- QLGN 226.0K
- Earning Date
- ZCMD 01-01-0001
- QLGN 11-29-2024
- Dividend Yield
- ZCMD N/A
- QLGN N/A
- EPS Growth
- ZCMD N/A
- QLGN N/A
- EPS
- ZCMD N/A
- QLGN N/A
- Revenue
- ZCMD $17,406,104.00
- QLGN N/A
- Revenue This Year
- ZCMD N/A
- QLGN N/A
- Revenue Next Year
- ZCMD N/A
- QLGN N/A
- P/E Ratio
- ZCMD N/A
- QLGN N/A
- Revenue Growth
- ZCMD 1.01
- QLGN N/A
- 52 Week Low
- ZCMD $1.00
- QLGN $3.55
- 52 Week High
- ZCMD $9.90
- QLGN $39.15
- Technical
- Relative Strength Index (RSI)
- ZCMD 36.47
- QLGN 25.42
- Support Level
- ZCMD $1.17
- QLGN $3.71
- Resistance Level
- ZCMD $1.28
- QLGN $4.56
- Average True Range (ATR)
- ZCMD 0.09
- QLGN 0.65
- MACD
- ZCMD -0.00
- QLGN -0.06
- Stochastic Oscillator
- ZCMD 6.25
- QLGN 2.08
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.